|
English
|
正體中文
|
简体中文
|
Total items :2856704
|
|
Visitors :
53743657
Online Users :
1312
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsueh"
Showing items 36-45 of 140 (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024 |
TiO2-based nitrogen dioxide gas sensor with transparent ordered micro-hollow bump structure prepared by 3D heterogeneous integration technology
|
Yeh;Y, -M.;Chang;S, -J.;Fang;S, -Y.;Hsueh;T, -J. |
| 國立成功大學 |
2024 |
Multispectral Imaging-Based System for Detecting Tissue Oxygen Saturation With Wound Segmentation for Monitoring Wound Healing
|
Lin;Chih-Lung;Wu;Meng-Hsuan;Ho;Yuan-Hao;Lin;Fang-Yi;Lu;Yu-Hsien;Hsueh;Yuan-Yu;Chen;Chia-Chen |
| 國立成功大學 |
2024 |
Big House, Small State: Taiwan’s Architecture of Island Precarity
|
McGrath;B;Hsueh;C, -L. |
| 國立成功大學 |
2024 |
Geographic differences in susceptibility profiles of potential non-class B carbapenemase-producing Enterobacterales isolates against ceftazidime-avibactam, meropenem-vaborbactam, colistin, amikacin, gentamicin, and tigecycline: Data from the Antimicrobial
|
Jean;S, -S.;Ko;W, -C.;Liu;I, -M.;Shieh;P, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–2021
|
Wang;J, -L.;Lai;C, -C.;Tsai;Y, -W.;Ko;W, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–21
|
Wang;J, -L.;Lai;C, -C.;Tsai;Y, -W.;Hsueh;C, -C.;Ko;W, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014–2021, and re-estimations of susceptibility breakpoin
|
Hsueh;S, -C.;Huang;Y, -T.;Ko;W, -C.;Liu;I, -M.;Shieh;P, -C.;Jean;S, -S. |
| 國立成功大學 |
2024 |
Minimum inhibitory concentrations of antifungals against invasive isolates of Cryptococcus species worldwide: Global antifungal antimicrobial testing leadership and surveillance program, 2010–2020
|
Jean;S, -S.;Liu;C, -Y.;Huang;Y, -T.;Ko;W, -C.;Ho;M, -W.;Liu;I, -M.;Shieh;P, -C.;Hsueh;P, -R. |
| 國立成功大學 |
2024 |
Poor in vitro activity of ceftazidime/avibactam against carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018 – 2021
|
Hsueh;C, -C.;Lai;C, -C.;Tsai;Y, -W.;Ko;W, -C.;Wang;J, -L. |
| 國立成功大學 |
2024 |
Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016–21
|
Wang;J, -L.;Lai;C, -C.;Ko;W, -C.;Hsueh;P, -R. |
Showing items 36-45 of 140 (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
